“Palo Alto-based Neurotrack, which has developed an online cognitive assessment test, raised $6.5 million in a round led by Khosla Ventures with participation from Social Capital, Founders Fund, AME Cloud Ventures, and iSeed Ventures. This brings Neurotrack’s total funding to $9.5 million.
Neurotrack has developed two offerings. The first is a five minute, web-based test, called Imprint Cognitive Assessment Test that evaluates whether a patient is at risk for Alzheimer’s…The company’s other product, which will work in conjunction with Imprint, is a web or app-based cognitive health intervention program that aims to help improve a user’s cognitive health…
While many are focused on finding a drug for Alzheimer’s, Kaplan said there’s other important work to be done too.
“As a result of this focus on getting to a drug, finding a drug — which is incredibly important, and we don’t want to lose sight of it — we have overlooked a really important body of scientific evidence coming out of Europe, US, other places that have shown that it’s possible to actually prevent cognitive decline using very specific changes in diet, exercise, cognitive training, managing your sleep, and managing your stress levels,” Kaplan said.
To learn more: